Curacle Co. Ltd.
curacle co.,ltd., a bio-venture business, engages in the research and development of drugs for intractable vascular and metabolic diseases due to aging. The company's products in pipeline include CU06, a next-generation oral therapy, which completed phase 2a clinical trial for the treatment of diabetic macular edema; CU01, which completed Phase 2b clinical trial for Nrf2 activation and inhibition… Read more
Market Cap & Net Worth: Curacle Co. Ltd. (365270)
Curacle Co. Ltd. (KQ:365270) has a market capitalization of $282.59 Million (₩413.77 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #15446 globally and #454 in its home market, demonstrating a 15.50% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Curacle Co. Ltd.'s stock price ₩19000.00 by its total outstanding shares 21777139 (21.78 Million).
Curacle Co. Ltd. Market Cap History: 2021 to 2026
Curacle Co. Ltd.'s market capitalization history from 2021 to 2026. Data shows change from $336.87 Million to $282.59 Million (-9.76% CAGR).
Index Memberships
Curacle Co. Ltd. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.11% | #166 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.11% | #166 of 1384 |
Weight: Curacle Co. Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Curacle Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Curacle Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Curacle Co. Ltd.'s market cap is 0.05 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $336.87 Million | $6.25 Billion | -$6.68 Billion | 0.05x | N/A |
| 2022 | $168.81 Million | $3.58 Billion | -$11.41 Billion | 0.05x | N/A |
| 2023 | $172.97 Million | $10.29 Billion | -$11.59 Billion | 0.02x | N/A |
| 2024 | $89.54 Million | $1.63 Billion | -$14.89 Billion | 0.05x | N/A |
Competitor Companies of 365270 by Market Capitalization
Companies near Curacle Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Curacle Co. Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Curacle Co. Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Curacle Co. Ltd.'s market cap moved from $336.87 Million to $ 282.59 Million, with a yearly change of -9.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩282.59 Million | +166.48% |
| 2025 | ₩106.04 Million | +18.44% |
| 2024 | ₩89.54 Million | -48.24% |
| 2023 | ₩172.97 Million | +2.47% |
| 2022 | ₩168.81 Million | -49.89% |
| 2021 | ₩336.87 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Curacle Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $282.59 Million USD |
| MoneyControl | $282.59 Million USD |
| MarketWatch | $282.59 Million USD |
| marketcap.company | $282.59 Million USD |
| Reuters | $282.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.